GeneDx Holdings Corp. (WGS)
66.24
-3.59
(-5.14%)
USD |
NASDAQ |
Apr 23, 16:00
67.03
+0.79
(+1.19%)
Pre-Market: 08:23
GeneDx Holdings EPS Diluted (Quarterly) : -0.6082 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Illumina, Inc. | 2.169 |
| Natera, Inc. | 0.3383 |
| Guardant Health, Inc. | -0.9987 |
| Delcath Systems, Inc. | -0.052 |
| CytoSorbents Corp. | -0.0875 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.67M |
| Revenue (Quarterly) | 120.99M |
| Total Expenses (Quarterly) | 138.66M |
| Enterprise Value | 1.882B |
| Gross Profit Margin (Quarterly) | 65.23% |
| Profit Margin (Quarterly) | -14.60% |
| Earnings Yield | -1.12% |
| Normalized Earnings Yield | -0.9846 |